Live
- LS polls: PM Modi says BJP-NDA leading 2-0 after first two phases
- Plea in Madras HC seeks special polling arrangement for names 'missing' from Coimbatore voter list
- Ex CM KCR Bus tour on 4 th day
- Youth National Games 2024 kick-start in Delhi; over 5,000 athletes from 15 states vying for top honours
- TN Police warn people against fraudsters using AI-based voice cloning
- L-G office blames Saurabh Bharadwaj for delay in enhancing MCD Commissioner's financial powers
- ICICI Bank posts 17 per cent rise in Q4 net profit at Rs 10,707cr; declares dividend of Rs 10 per share
- 26/11 prosecutor to Mumbai North Central candidate - Ujjwal Nikam all set for 'new innings' with BJP
- CBI traces shop that sold bullets & cartridges seized from Sandeshkhali
- IPL 2024: Rasikh and Mukesh pick three-fers as Delhi Capitals beat Mumbai Indians by 10 runs
Cyient inks pact with Agappe
Cyient inks pact with Agappe
IT major Cyient has signed a manufacturing partnership with Agappe to bring indigenously developed diagnostic machine Count X to market.Mispa Count X is an indigenously designed and developed three-part haematologyanalyser, involving study and treatment of the blood, by Agappe that enables setting up of well-equipped labs in remote and rural locations across India.
Hyderabad: IT major Cyient has signed a manufacturing partnership with Agappe to bring indigenously developed diagnostic machine to market.Mispa Count X is an indigenously designed and developed three-part haematology analyser, involving study and treatment of the blood, by Agappe that enables setting up of well-equipped labs in remote and rural locations across India.
As per the agreement, Cyient will manufacture certain key components of Mispa Count X at its ISO 13485-certified, state-of-art manufacturing facilities in India.
In a regulatory filing, Cyient DLM senior V-P and CEO Rajendra Velagapudi said: "We are proud to support the vision of an Atmanirbhar Bharat (self-reliant India) in the healthcare sector.
It is a matter of immense pride that with Agappe's new haematology product, even rural India and other remote locations of the country will have access to the best of diagnostic capabilities."
